Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

Ajai Chari, Attaya Suvannasankha, Joseph W. Fay, Bertrand Arnulf, Jonathan L. Kaufman, Jainulabdeen J. Ifthikharuddin, Brendan M. Weiss, Amrita Krishnan, Suzanne Lentzsch, Raymond Comenzo, Jianping Wang, Kerri Nottage, Christopher Chiu, Nushmia Z. Khokhar, Tahamtan Ahmadi, Sagar Lonial

Blood (2017) 130 (8): 974–981.

https://doi.org/10.1182/blood-2017-05-785246

Published: 2017

Includes: Supplemental data

Journal Articles

Molecular Predictors of Outcome and Drug Response in Multiple Myeloma: An Interim Analysis of the Mmrf CoMMpass Study

Blood (2016) 128 (22): 194.

https://doi.org/10.1182/blood.V128.22.194.194

Published: 2016

Journal Articles

Open-Label, Multicenter, Phase 1b Study of Daratumumab in Combination with Pomalidomide and Dexamethasone in Patients with at Least 2 Lines of Prior Therapy and Relapsed or Relapsed and Refractory Multiple Myeloma

Ajai Chari, MD, Sagar Lonial, MD, Attaya Suvannasankha, Joseph W. Fay, Bertrand Arnulf, Jainulabdeen J. Ifthikharuddin, Xiang Qin, Tara Masterson, Kerri Nottage, Jordan M Schecter, Tahamtan Ahmadi, Brendan Weiss, Amrita Krishnan, Suzanne Lentzsch

Blood (2015) 126 (23): 508.

https://doi.org/10.1182/blood.V126.23.508.508

Published: 2015

Journal Articles

Identification of Initiating Trunk Mutations and Distinct Molecular Subtypes: An Interim Analysis of the Mmrf Commpass Study

Blood (2015) 126 (23): 722.

https://doi.org/10.1182/blood.V126.23.722.722

Published: 2015

Journal Articles

An Open-Label, Multicenter, Phase 1b Study of Daratumumab in Combination with Backbone Regimens in Patients with Multiple Myeloma

Philippe Moreau, MD, Maria-Victoria Mateos, Joan Bladé, MD PhD, Lotfi Benboubker, MD PhD, Javier de la Rubia, MD PhD, Thierry Facon, MD, Raymond L. Comenzo, MD, Joseph W. Fay, MD, Xiang Qin, MS, Tara Masterson, MS, Jordan Schecter, MD, Tahamtan Ahmadi, MD, Jesus San Miguel, MD PhD

Blood (2014) 124 (21): 176.

https://doi.org/10.1182/blood.V124.21.176.176

Published: 2014

Journal Articles

The Multiple Myeloma Research Consortium (MMRC): A Model For Accelerating Development Of Novel Therapies For Multiple Myeloma

Beverly Harrison, Kenneth C. Anderson, MD, Noopur Raje, MD, Paul Richardson, MD, Diane Warren, Ajai Chari, MD, Sundar Jagannath, MD, Lisa La, Jesus Berdeja, MD, Meredith Zimlich, Joseph W. Fay, MD, Sheila Powell, RN, Craig C Hofmeister, MD, Nita Williams, BS, Andrzej J. Jakubowiak, MD, PhD, Todd M. Zimmerman, MD, Kathryn McDonnell, Amrita Y. Krishnan, MD, Lupe Duarte, CCRC, Shaji K Kumar, MD, Ann Birgin, CRA, Sagar Lonial, M.D., Kenisha Baron, Thomas Martin, MD, Jeffrey L Wolf, MD, Geraldine Pelle-Day, Ph.D., Glenna Auerback, Gregory Orloff, MD, Nikki Hodge, Donna E Reece, MD, FRCPC, Suzanne Trudel, MD, Engin Gul, HonBSc, Vivek Roy, M.D., Michele Maharaj, RN, David S. Siegel, MD, PhD, Adolfo Aleman, A. Keith Stewart, Rachel Hagerty, Moshe Talpaz, MD, Roxane Collins, Ravi Vij, MD, Mark A. Fiala, BS, CCRP, Jeffrey Zonder, M.D., Silva Pregja, Sharon Goldberg, Joan Levy, PhD, Karen Dietz, Walter Capone, Daniel Auclair, PhD, Anne Quinn Young, Kathy Giusti, MBA

Blood (2013) 122 (21): 5388.

https://doi.org/10.1182/blood.V122.21.5388.5388

Published: 2013

Journal Articles

Efficacy Of a Pharmacokinetics-Directed IV Busulfan (Bu), Plus Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen With Autologous Hematopoietic Stem Cell Transplantation For Lymphoma: Final Report Of a Multi-Center Phase 2 Study In North America

Blood (2013) 122 (21): 768.

https://doi.org/10.1182/blood.V122.21.768.768

Published: 2013

Journal Articles

A Phase 1 Study Of ARRY-520 With Bortezomib (BTZ) and Dexamethasone (dex) In Relapsed Or Refractory Multiple Myeloma (RRMM)

Ajai Chari, MD, Myo Htut, MD, Jeffrey Zonder, M.D., Joseph W. Fay, MD, Andrzej J Jakubowiak, MD, PhD, Beverly Harrison, Kenneth Lau, BA, Brandi Hilder, Ann Ptaszynski, Selena A Rush, BS, Jonathan L. Kaufman, MD, Steven Michael Burt

Blood (2013) 122 (21): 1938.

https://doi.org/10.1182/blood.V122.21.1938.1938

Published: 2013

Journal Articles

The Multiple Myeloma Research Consortium (MMRC): Accelerated Start up and Accrual Metrics Speeds Drug Development

Blood (2011) 118 (21): 1024.

https://doi.org/10.1182/blood.V118.21.1024.1024

Published: 2011

Journal Articles

Effect of Stem Cell Source From Unrelated Donors on Transplant Outcomes In Severe Aplastic Anemia (SAA): a Comparison of Unrelated Bone Marrow (BM) and Peripheral Blood Progenitor Cells (PBPC)

Mary Eapen, MBBS, Jennifer LeRademacher, PhD, H. Joachim Deeg, Joseph H. Antin, MD, Richard Champlin, Jeanette Carreras, MPH, Joseph W. Fay, MD, Jakob R. Passweg, MD, MS, Jakub Tolar, MD, PhD, Judith C. W. Marsh, MD, Mary M. Horowitz, MD, MS

Blood (2010) 116 (21): 531.

https://doi.org/10.1182/blood.V116.21.531.531

Published: 2010

Journal Articles

The Humanized Anti PD-1 Antibody, CT-011, Increases Specific CD4+ Effector/Memory and Memory T Lymphocytes in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Following Autologous Stem Cell Transplantation (AuSCT).

Rinat Rotem-Yehudar, PhD, Philippe Armand, MD, PhD, Steve Devine, MD, Joseph W. Fay, MD, Chitra Hosing, MD, Markus Y Mapara, Erica Campagnero, MD, Joseph P. Uberti, MD, PhD, David Avigan, MD, Karen K Ballen, MD, Jane N. Winter, MD, Arnon Nagler, MD, Leo I. Gordon, MD

Blood (2009) 114 (22): 1216.

https://doi.org/10.1182/blood.V114.22.1216.1216

Published: 2009

Journal Articles

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease

Paul J. Martin, Barry E. Storer, Scott D. Rowley, Mary E. D. Flowers, Stephanie J. Lee, Paul A. Carpenter, John R. Wingard, Paul J. Shaughnessy, Marcel P. DeVetten, Madan Jagasia, Joseph W. Fay, Koen van Besien, Vikas Gupta, Carrie Kitko, Laura J. Johnston, Richard T. Maziarz, Mukta Arora, Pamala A. Jacobson, Daniel Weisdorf

Blood (2009) 113 (21): 5074–5082.

https://doi.org/10.1182/blood-2009-02-202937

Published: 2009

Includes: Supplemental data

Journal Articles

Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan (CLO/BU) Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies

Edward Agura, MD, R. Brian Berryman, MD, Luis Pineiro, MD, Mirjana Tadic-Ovcina, Ryan Woelfel, Estil A. Vance, MD, Joseph W. Fay, MD

Blood (2008) 112 (11): 4320.

https://doi.org/10.1182/blood.V112.11.4320.4320

Published: 2008

Journal Articles

Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies and Diseases.

Edward D. Agura, MD, R. Brian Berryman, MD, Joseph W. Fay, MD, FACP, Luis A. Pineiro, MD, Estil A. Vance, MD, Mirjana Tadic-Ovcina

Blood (2007) 110 (11): 4954.

https://doi.org/10.1182/blood.V110.11.4954.4954

Published: 2007

Journal Articles

Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations

Blood (2005) 105 (4): 1408–1416.

https://doi.org/10.1182/blood-2004-06-2385

Published: 2005

Journal Articles

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study

Catherine Metayer, Rochelle E. Curtis, Julie Vose, Kathleen A. Sobocinski, Mary M. Horowitz, Smita Bhatia, Joseph W. Fay, Cesar O. Freytes, Steven C. Goldstein, Roger H. Herzig, Armand Keating, Carol B. Miller, Thomas J. Nevill, Andrew L. Pecora, J. Douglas Rizzo, Stephanie F. Williams, Chin-Yang Li, Lois B. Travis, Daniel J. Weisdorf

Blood (2003) 101 (5): 2015–2023.

https://doi.org/10.1182/blood-2002-04-1261

Published: 2003

Journal Articles

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

Richard A. Nash, Joseph H. Antin, Chatchada Karanes, Joseph W. Fay, Belinda R. Avalos, Andrew M. Yeager, Donna Przepiorka, Stella Davies, Finn B. Petersen, Pamela Bartels, Donald Buell, William Fitzsimmons, Claudio Anasetti, Rainer Storb, Voravit Ratanatharathorn

Blood (2000) 96 (6): 2062–2068.

https://doi.org/10.1182/blood.V96.6.2062

Published: 2000

Journal Articles

Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

Blood (1998) 92 (7): 2303–2314.

https://doi.org/10.1182/blood.V92.7.2303

Published: 1998

Journal Articles

A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation

Blood (1998) 91 (9): 3509–3517.

https://doi.org/10.1182/blood.V91.9.3509

Published: 1998

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

Molecular Predictors of Outcome and Drug Response in Multiple Myeloma: An Interim Analysis of the Mmrf CoMMpass Study

Open-Label, Multicenter, Phase 1b Study of Daratumumab in Combination with Pomalidomide and Dexamethasone in Patients with at Least 2 Lines of Prior Therapy and Relapsed or Relapsed and Refractory Multiple Myeloma

Identification of Initiating Trunk Mutations and Distinct Molecular Subtypes: An Interim Analysis of the Mmrf Commpass Study

An Open-Label, Multicenter, Phase 1b Study of Daratumumab in Combination with Backbone Regimens in Patients with Multiple Myeloma

The Multiple Myeloma Research Consortium (MMRC): A Model For Accelerating Development Of Novel Therapies For Multiple Myeloma

Efficacy Of a Pharmacokinetics-Directed IV Busulfan (Bu), Plus Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen With Autologous Hematopoietic Stem Cell Transplantation For Lymphoma: Final Report Of a Multi-Center Phase 2 Study In North America

A Phase 1 Study Of ARRY-520 With Bortezomib (BTZ) and Dexamethasone (dex) In Relapsed Or Refractory Multiple Myeloma (RRMM)

The Multiple Myeloma Research Consortium (MMRC): Accelerated Start up and Accrual Metrics Speeds Drug Development

Effect of Stem Cell Source From Unrelated Donors on Transplant Outcomes In Severe Aplastic Anemia (SAA): a Comparison of Unrelated Bone Marrow (BM) and Peripheral Blood Progenitor Cells (PBPC)

The Humanized Anti PD-1 Antibody, CT-011, Increases Specific CD4+ Effector/Memory and Memory T Lymphocytes in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Following Autologous Stem Cell Transplantation (AuSCT).

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease

Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan (CLO/BU) Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies

Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies and Diseases.

Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only